Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Legato Merger III | LEGT | Nov 27, 2024 | 10.28 | +0.05 |
Legend Biotech ADR | LEGN | Nov 27, 2024 | 43.13 | +1.29 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Nov 27, 2024 | 41.24 | +0.18 |
Leggett & Platt | LEG | Nov 27, 2024 | 12.58 | +0.72 |
Leidos | LDOS | Nov 27, 2024 | 163.97 | -1.29 |
LeMaitre Vascular | LMAT | Nov 27, 2024 | 105.80 | +0.36 |
Lemonade | LMND | Nov 27, 2024 | 49.16 | -1.54 |
LendingClub | LC | Nov 27, 2024 | 16.49 | +0.92 |
LendingTree | TREE | Nov 27, 2024 | 43.85 | +0.34 |
Lendway | LDWY | Nov 27, 2024 | 4.41 | -4.96 |
Lennar A | LEN | Nov 27, 2024 | 174.10 | +0.40 |
Lennar B | LEN-B | Nov 27, 2024 | 164.37 | +0.46 |
Lennox International | LII | Nov 27, 2024 | 660.04 | -0.93 |
LENSAR | LNSR | Nov 27, 2024 | 7.69 | +3.36 |
LENZ Therapeutics | LENZ | Nov 27, 2024 | 37.30 | +2.90 |
Leonardo DRS | DRS | Nov 27, 2024 | 34.66 | -0.60 |
Lesaka Technologies | LSAK | Nov 27, 2024 | 5.43 | +3.43 |
Leslies | LESL | Nov 27, 2024 | 2.48 | +1.22 |
Levi Strauss & Co A | LEVI | Nov 27, 2024 | 16.91 | +0.77 |
Lexaria Bioscience | LEXX | Nov 27, 2024 | 2.09 | -1.88 |
Lexeo Therapeutics | LXEO | Nov 27, 2024 | 7.83 | +6.82 |
Lexicon Pharmaceuticals | LXRX | Nov 27, 2024 | 0.80 | -1.87 |
LexinFintech ADR | LX | Nov 27, 2024 | 4.90 | +14.75 |
LG Display ADR | LPL | Nov 27, 2024 | 3.47 | -0.29 |
LGI Homes | LGIH | Nov 27, 2024 | 110.30 | +1.10 |
LGL Group | LGL | Nov 27, 2024 | 5.85 | -2.50 |
Li Auto ADR | LI | Nov 27, 2024 | 23.31 | +6.78 |
Li Bang International | LBGJ | Nov 27, 2024 | 3.30 | 0.00 |
Li-Cycle | LICY | Nov 27, 2024 | 2.17 | +0.93 |
Liberty Allstar Equity Fund | USA | Nov 27, 2024 | 7.28 | -0.27 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.